Literature DB >> 843702

Reversal of morphine-induced suppression of active avoidance behaviour by the tetracyclic antidepressant mianserin [proceedings].

E Preston, H Rigter, C Strijbos, E Schönbaum.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 843702      PMCID： PMC1668008     

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN： 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  5 in total

1.  The effect of morphine sulfate on avoidance and escape behavior.

Authors:  T VERHAVE; J E OWEN; E B ROBBINS
Journal:  J Pharmacol Exp Ther       Date:  1959-03       Impact factor: 4.030

2.  Antagonism by methysergide and cinanserin of the antinociceptive action of morphine administered into the periaqueductal gray.

Authors:  T L Yaksh; J C DuChateau; T A Rudy
Journal:  Brain Res       Date:  1976-03-12       Impact factor: 3.252

3.  Different central effects of the 5-HT antagonists mianserine and cyproheptadine.

Authors:  H van Riezen
Journal:  Arch Int Pharmacodyn Ther       Date:  1972-08

4.  Mianserin hydrochloride: peripheral and central effects in relation to antagonism against 5-hydroxytryptamine and tryptamine.

Authors:  B B Vargaftig; J L Coignet; C J de Vos; H Grijsen; I L Bonta
Journal:  Eur J Pharmacol       Date:  1971 Nov-Dec       Impact factor: 4.432

5.  Controlled clinical trial of a new antidepressant (Org. GB 94) of novel chemical formulation.

Authors:  D Wheatley
Journal:  Curr Ther Res Clin Exp       Date:  1975-12
  5 in total
  2 in total

1.  Differences in presynaptic alpha-blockade, noradrenaline uptake inhibition, and potential antidepressant activity between (+)- and (-)mianserin.

Authors:  H Schoemaker; H H Berendsen; H J Stevens; V J Nickolson
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

Review 2.  Mianserin: a review of its pharmacological properties and therapeutic efficacy in depressive illness.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-10       Impact factor: 9.546
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.